{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:15:06Z","timestamp":1791890106292,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.cgh.2017.02.041","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T17:09:10Z","timestamp":1490202550000},"page":"1232-1241.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8754-9722","authenticated-orcid":false,"given":"Shannon L.","family":"Kanis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"de Lima-Karagiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanne K.H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Janneke","family":"van der Woude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2017.02.041_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.041_bib2","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/0016-5085(90)90617-A","article-title":"Increased risk of preterm birth for women with inflammatory bowel-disease","volume":"99","author":"Baird","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.041_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0020-7292(97)00088-X","article-title":"Fertility and pregnancy in inflammatory bowel disease","volume":"58","author":"Hudson","year":"1997","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.cgh.2017.02.041_bib4","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/j.1572-0241.2006.00602.x","article-title":"Does pregnancy change the disease course? a study in a European cohort of patients with inflammatory bowel disease","volume":"101","author":"Riis","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.041_bib5","first-page":"741","article-title":"Inflammatory bowel disease, women, and pregnancy","volume":"9","author":"Kane","year":"2013","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"10.1016\/j.cgh.2017.02.041_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/ajg.2016.254","article-title":"The effects of active IBD during pregnancy in the era of novel IBD therapies","volume":"111","author":"de Lima-Karagiannis","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.041_bib7","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S1873-9946(14)60060-X","article-title":"Early assessment of thiopurine metabolites predicts the occurrence of leukopenia in inflammatory bowel disease patients","volume":"8","author":"Wong","year":"2014","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2017.02.041_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S1542-3565(04)00344-1","article-title":"Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety","volume":"2","author":"Dubinsky","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2017.02.041_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/00007691-200406000-00016","article-title":"Pharmacokinetics of 6-mercaptopurine in patients with inflammatory bowel disease: implications for therapy","volume":"26","author":"Derijks","year":"2004","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.cgh.2017.02.041_bib10","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/j.1572-0241.2006.00538.x","article-title":"Azathioprine use during pregnancy: unexpected intrauterine exposure to metabolites","volume":"101","author":"de Boer","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.041_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1136\/gutjnl-2012-303615","article-title":"Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease","volume":"63","author":"Jharap","year":"2014","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.041_bib12","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/tera.10043","article-title":"Teratogen update: azathioprine and 6-mercaptopurine","volume":"65","author":"Polifka","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.cgh.2017.02.041_bib13","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ajg.2012.430","article-title":"Safety of thiopurines and anti-TNF-\u03b1 drugs during pregnancy in patients with inflammatory bowel disease","volume":"108","author":"Casanova","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2017.02.041_bib14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/gut.2010.222893","article-title":"Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study","volume":"60","author":"Coelho","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.041_bib15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.crohns.2011.01.009","article-title":"The effects of azathioprine on birth outcomes in women with inflammatory bowel disease (IBD)","volume":"5","author":"Shim","year":"2011","journal-title":"J\u00a0Crohn's Colitis"},{"key":"10.1016\/j.cgh.2017.02.041_bib16","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/bdra.20583","article-title":"Early pregnancy azathioprine use and pregnancy outcomes","volume":"85","author":"Cleary","year":"2009","journal-title":"Birth Defects Res Part A Clin Mol Teratol"},{"key":"10.1016\/j.cgh.2017.02.041_bib17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1046\/j.1365-2036.2003.01537.x","article-title":"Azathioprine, mercaptopurine and birth outcome: a population-based cohort study","volume":"17","author":"Norgard","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.02.041_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1365-2036.2006.03162.x","article-title":"Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study","volume":"25","author":"Langagergaard","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.02.041_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/apt.12334","article-title":"Long-term follow-up of children exposed intrauterine to maternal thiopurine therapy during pregnancy in females with inflammatory bowel disease","volume":"38","author":"de Meij","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2017.02.041_bib20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/ecco-jcc\/jju006","article-title":"The second European evidenced-based consensus on reproduction and pregnancy in inflammatory bowel disease","volume":"9","author":"van der Woude","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2017.02.041_bib21","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1053\/j.gastro.2015.12.003","article-title":"The Toronto consensus statements for the management of inflammatory bowel disease in pregnancy","volume":"150","author":"Nguyen","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.041_bib22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1136\/gutjnl-2015-309321","article-title":"Tailored anti-TNF therapy during pregnancy in patients with IBD: maternal and fetal safety","volume":"65","author":"de Lima","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.041_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/HUMREP\/11.2.406","article-title":"A\u00a0prospective study of early pregnancy loss","volume":"11","author":"Ellish","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cgh.2017.02.041_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/jac\/dkh062","article-title":"Trends in prescribing antibiotics for children in Dutch general practice","volume":"53","author":"Otters","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cgh.2017.02.041_bib25","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.earlhumdev.2009.09.008","article-title":"New Dutch reference curves for birthweight by gestational age","volume":"85","author":"Visser","year":"2009","journal-title":"Early Hum Dev"},{"key":"10.1016\/j.cgh.2017.02.041_bib26","unstructured":"European Surveillance of Congenital Anomalies. EUROCAT guide 1.3 and reference documents: instructions for the registration and surveillance of congenital anomalies. Available at: http:\/\/www.eurocat-network.eu\/content\/EUROCAT-Guide-1.3.pdf. Accessed May 14,\u00a02010."},{"issue":"Suppl 1","key":"10.1016\/j.cgh.2017.02.041_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1742-4755-10-S1-S3","article-title":"Born too soon: care before and between pregnancy to prevent preterm births\u2014from evidence to action","volume":"10","author":"Dean","year":"2013","journal-title":"Reprod Health"},{"key":"10.1016\/j.cgh.2017.02.041_bib28","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1128\/IAI.00535-10","article-title":"Preterm infants have deficient monocyte and lymphocyte cytokine responses to group B streptococcus","volume":"79","author":"Currie","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.cgh.2017.02.041_bib29","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/sji.12474","article-title":"Percentiles of lymphocyte subsets in preterm infants according to gestational age compared to children and adolescents","volume":"84","author":"Huenecke","year":"2016","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.cgh.2017.02.041_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0015-0282(16)58144-8","article-title":"Estimates of human fertility and pregnancy loss","volume":"65","author":"Zinaman","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.cgh.2017.02.041_bib31","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0301-2115(01)00613-3","article-title":"Risk factors in miscarriage: a review","volume":"102","author":"Garcia-Enguidanos","year":"2002","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.cgh.2017.02.041_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-2007-992927","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"26","author":"Boomsma","year":"2008","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.cgh.2017.02.041_bib33","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1136\/bmj.297.6655.1027","article-title":"Recurrent early miscarriage and polycystic ovaries","volume":"297","author":"Sagle","year":"1988","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2017.02.041_bib34","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.humrep.a138174","article-title":"Miscarriage rates following in-vitro fertilization are increased in women with polycystic ovaries and reduced by pituitary desensitization with buserelin","volume":"8","author":"Balen","year":"1993","journal-title":"Hum Reprod"},{"key":"10.1016\/j.cgh.2017.02.041_bib35","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.25.1.52","article-title":"Crohn's disease and pregnancy","volume":"25","author":"Khosla","year":"1984","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2017.02.041_bib36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1053\/j.gastro.2007.07.019","article-title":"Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California","volume":"133","author":"Mahadevan","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2017.02.041_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.crohns.2011.02.003","article-title":"Conception and pregnancy outcome in women with inflammatory bowel disease: a multicentre study from Japan","volume":"5","author":"Naganuma","year":"2011","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2017.02.041_bib38","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ajog.2013.01.009","article-title":"Ethical aspects of paternal preconception lifestyle modification","volume":"209","author":"van der Zee","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cgh.2017.02.041_bib39","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12978-016-0156-6","article-title":"Investigating paternal preconception risk factors for adverse pregnancy outcomes in a population of internet users","volume":"13","author":"Agricola","year":"2016","journal-title":"Reprod Health"},{"key":"10.1016\/j.cgh.2017.02.041_bib40","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/bdra.23231","article-title":"Seasonality of congenital anomalies in Europe","volume":"100","author":"Luteijn","year":"2014","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.cgh.2017.02.041_bib41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.cgh.2016.03.018","article-title":"Preconception care reduces relapse of inflammatory bowel disease during pregnancy","volume":"14","author":"de Lima","year":"2016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517303191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356517303191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:22:06Z","timestamp":1761542526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356517303191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1542356517303191"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2017.02.041","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Thiopurines During Conception and Pregnancy Is Not Associated With Adverse Pregnancy Outcomes or Health of Infants at One Year in a Prospective Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2017.02.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the AGA Institute","name":"copyright","label":"Copyright"}]}}